Register
Question 1
What is the typical study focus during Phase II trials?
Correct Answer:
Therapeutic exploratory analysis
Explanation:
During Phase II trials, the primary focus is on therapeutic exploratory analysis. This phase aims to evaluate the efficacy of a drug or treatment and assess its pharmacodynamics and optimal dosing parameters. Researchers seek to gather preliminary data on how well the treatment works in a specific patient population who have the condition the treatment aims to address. In contrast, safety analysis is often a focus in Phase I trials, where the primary goal is to assess how the drug affects the human body and to identify any potential side effects. Large simple trials refer to studies designed to investigate broad efficacy in a practical, less controlled setting, typically not confined to Phase II. Therapeutic confirmatory analysis occurs in Phase III trials, where the main goal is to confirm the efficacy and monitor adverse reactions in a larger population to support regulatory approval. Thus, therapeutic exploratory analysis distinctly characterizes Phase II, making it the correct choice.
Question 2
What document records the exposure to experimental products during a study?
Correct Answer:
The case report form (CRF)
Explanation:
The case report form (CRF) is the correct choice as it is specifically designed to record all pertinent data regarding each participant in a clinical trial, including their exposure to the experimental products being studied. The CRF captures detailed information such as dosing information, timing of administration, and any adverse events experienced during the study. This documentation is crucial for the analysis of the data generated during the trial and to ensure that all regulatory requirements are met. In contrast, the consent form is focused on informing participants about the study and obtaining their permission to participate, but it does not detail individual exposure to the treatment. The billing statement typically relates to the costs incurred during the trial, rather than recording study-related data. The final study report summarizes the outcomes and findings of the study as a whole and does not capture individual subject data directly related to their exposure to the experimental product. Therefore, the case report form is the essential tool for recording exposure during a clinical study.
Question 3
Which of the following is an example of a labor cost in clinical research?
Correct Answer:
Clinical Research Assistants or Associates (CRAs)
Explanation:
In clinical research, labor costs refer to the expenses associated with the personnel involved in conducting the study. Clinical Research Assistants or Associates (CRAs) are essential team members who perform various tasks necessary for the successful completion of clinical trials, such as participant recruitment, data collection, and compliance with regulatory requirements. Their salaries and associated labor-related expenses are categorized as direct labor costs because they directly contribute to the execution of the research activities. The other choices represent different types of costs. Office supplies pertain to operational overhead but do not specifically reflect the cost of labor. Trial marketing expenses are related to promoting the clinical trial, which is also not a labor cost. Insurance premiums are necessary for covering risk but are not tied to the workforce's direct labor in the research context. Thus, the costs incurred for personnel like Clinical Research Assistants or Associates are the quintessential example of labor costs in clinical research.
Question 4
What step can a Sponsor take if they do not agree with the Investigator's causality assessment of an event?
Correct Answer:
They can upgrade the relatedness from 'no' to 'yes'
Explanation:
When assessing the causality of an adverse event, it's crucial to understand the roles and responsibilities of both the Investigator and the Sponsor. The Investigator typically conducts an initial assessment based on their clinical judgment and the information available at the time. However, the Sponsor has an overarching responsibility to ensure the safety of study participants and the integrity of the research data. If a Sponsor disagrees with the Investigator's causality assessment, they can indeed upgrade the relatedness from 'no' to 'yes.' This means the Sponsor may classify an event as related to the study drug when the Investigator has deemed it unrelated. This action might stem from additional information that the Sponsor possesses, which was not available to the Investigator. For instance, data from other studies, reports, or consultations with a safety monitoring board could influence the Sponsor's perspective on potential causality. It's essential for the Sponsor to communicate any significant discrepancies transparently, as these decisions can impact the safety monitoring of the study and regulatory reporting obligations. The relationship between the Investigator's and Sponsor's assessments is cooperative, but in situations where discrepancies arise regarding event causality, the Sponsor is empowered to make modifications in the interest of participant safety and compliance with regulatory requirements.
Question 5
Which of the following reports is NOT typically submitted to the FDA once an IND application becomes effective?
Correct Answer:
Patient recruitment strategies
Explanation:
The correct answer is the report regarding patient recruitment strategies. Once an Investigational New Drug (IND) application becomes effective, the FDA requires several specific types of reports related to the clinical trial, such as safety monitoring, study progress, and information regarding the overall conduct of the trial. Adverse event reports must be submitted to inform the FDA about any unexpected or serious adverse events that occur during the study. Annual reports are required to summarize the progress of clinical studies, including new safety information and updates on the overall trial conduct. Final reports are submitted at the end of the trial to provide comprehensive data on the outcomes and findings. In contrast, patient recruitment strategies are not submitted to the FDA as a formal report. While the FDA is interested in the conduct of the trial and monitoring safety, specific recruitment strategies themselves are considered part of the operational and logistical aspects of how a clinical trial is run rather than a formal requirement for reporting. Therefore, this makes it the correct choice for the question regarding which report is NOT typically submitted to the FDA once an IND application is effective.
Question 1
Exam overview

About this Exam

The Certified Clinical Research Associate (CCRA) designation is a globally recognized certification that validates the knowledge, skills, and abilities required to effectively perform as a Clinical Research Associate (CRA). It is designed for clinical research professionals with verifiable experience in the field, who are responsible for monitoring clinical trials to ensure they are conducted according to the protocol, standard operating procedures (SOPs), Good Clinical Practice (GCP), and applicable regulatory requirements. This certification is a key milestone for professionals who want to demonstrate their commitment to the industry and elevate their career prospects within clinical research.

More details

Additional Information

What the Course Entails and Exam Details

  • Preparing for the CCRA exam requires a deep understanding of the core competencies of a CRA. While there is no mandatory "course" that all candidates must take, candidates are expected to be proficient in the knowledge domains defined Study and Site Management: The lifecycle of a clinical trial, from pre-study visits and site selection to initiation, routine monitoring, and close-out activities. This includes essential document management and record retention.
  • Monitor Responsibilities: Key tasks such as source data verification, investigational product accountability, safety reporting (AE/SAE), and managing protocol deviations.
  • Data Management and Informatics: Principles of data collection, electronic data capture (EDC), data privacy, and the monitor’s role in ensuring data integrity.
  • Safety Monitoring and Pharmacovigilance: Understanding of safety reporting requirements, regulatory authority notification timelines, and safety data analysis.

 

What to Expect in the Final Exam

The final CCRA exam is a standardized, computer-based test that assesses the application of knowledge, not just memorization. Candidates can expect the following general format:

  • Question Format: The exam typically consists of 125 multiple-choice questions. A portion of these (around 25) are pre-test items that are unscored and used for future exam development; however, you will not know which questions are unscored, so it is crucial to answer all to the best of your ability.
  • Time Limit: Candidates are usually allocated 3 hours to complete the examination.
  • Passing Score: The passing score is determined using a scaled scoring method. While there is no fixed number of correct answers, a common scaled score required to pass is 500, with raw scores generally translating to a percentage range in the mid-to-high 70s.
  • Language: The primary language for the exam is English.
  • No Negative Marking: There is no penalty for incorrect answers, so it is in your best interest to attempt every question.

 

 How to Study and Exam Centers

The key to passing the CCRA exam is a blend of formal study and practical experience. Here are actionable strategies:

How to Study:

Start with the Source: Download the current ACRP CCRA Candidate Handbook. It is your definitive guide for eligibility, the detailed Content Outline, and exam policies. This document specifies exactly what knowledge domains you will be tested on and their relative weight.

Master foundational documents: Read and re-read the ICH GCP E6 (R2) guideline until you can apply its principles to various real-world monitoring scenarios.

Take CCRA Practice Exams: Invest in official ACRP practice exams. These are essential for familiarizing yourself with the types of questions, the logic used, and identifying gaps in your knowledge. Many candidates also use third-party CCRA Practice Exam resources to broaden their preparation.

Leverage professional development: Attend ACRP’s webinar series, local chapter events, or structured review courses specifically designed for CCRA preparation.

Form study groups: Collaborating with peers who are also preparing can provide new insights, particularly when discussing complex case studies.

Exam Centers:

The CCRA exam is administered through a network of professional testing centers. ACRP currently partners with Prometric for secure testing.

  • Physical Testing Centers: You can schedule your exam at any authorized Prometric testing center worldwide. These facilities offer a standardized, proctored environment.
  • Online Proctoring: For increased flexibility, safe and secure online proctoring is also often an option, allowing you to take the exam from your own home or office, provided you meet the strict technical and environmental requirements.
  • Authorized Locations: Always use the links provided in your approved exam application from ACRP to schedule your test, ensuring you only use official, authorized locations or platforms.

 

 Job Opportunities from the Course

Earning your CCRA certification can unlock numerous career paths and signify significant professional achievement within the life sciences sector. Below is a list of job titles and career paths commonly advanced by this credential:

  • Clinical Research Associate (CRA) / Senior CRA: The primary role validated by the certification.
  • CRA Manager / Clinical Operations Manager: Leading and mentoring teams of CRAs and managing monitoring operations.
  • Clinical Trial Monitor: Specialized monitoring focus, often for a CRO.
  • Clinical Research Auditor / Quality Assurance Associate: Pivoting into independent audits and GCP compliance oversight.
  • Project Manager: Transitioning from site monitoring to overall study project management.
  • Clinical Research Director / Head of Clinical Operations: Upper-level management of a company’s clinical trial portfolio.
  • Clinical Trial Educator / Trainer: Developing and delivering GCP and monitoring training.
  • Regulatory Affairs Associate / Manager: Utilizing GCP knowledge in regulatory interactions.
Quiz information

Frequently Asked Questions

The complete question count is available after full access is unlocked.
No fixed duration is currently configured for this quiz.
Question explanations are included where they are available in the quiz content, helping you review the reasoning after answering.
Yes. You can retake the practice test again as you continue studying during your available access period.
After your access is confirmed, you can continue into the complete practice exam from this quiz flow.
Unless explicitly stated otherwise, this page provides independent practice material for study and exam preparation and is not the official examination itself.
Keep studying

Related Questions

ISC2 Certified in Cybersecurity Practice Exam

0 min

ArcGIS Online Administration Associate Practice Test

0 min

ArcGIS Online Administration Associate Practice Test

0 min

Arizona CNA Certified Nursing Assistant Practice Exam

0 min

Certified Professional Public Buyer (CPPB) Practice Exam

0 min

Certified Specialist Business Intelligence (CSBI) Practice Test

0 min